Low doses of pharmaceutically extracted nicotine, distinct from tobacco, can positively impact cognitive function and longevity by raising PGC1 alpha levels, potentially reducing the risk of Alzheimer's and Parkinson's diseases. This low dose shows promise as a potent nootropic and exercise mimetic. Pharmaceutical nicotine, when taken in the range of one to five milligrams for individuals over 40, may have beneficial effects on cognitive function and nicotinic acid receptors due to its impact on PGC1 alpha levels.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode